AlbireoPharma - Product Pipeline Review - 2015

01:13 EDT 15 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, AlbireoPharma - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-02-27. This 32-page report is available in PDF from $1500.

AlbireoPharma - Product Pipeline Review - 2015


Global Markets Direct’s, ‘AlbireoPharma - Product Pipeline Review - 2015’, provides an overview of the AlbireoPharma’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AlbireoPharma’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of AlbireoPharma including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of AlbireoPharma’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the AlbireoPharma’s pipeline products

Reasons to buy

- Evaluate AlbireoPharma’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of AlbireoPharma in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the AlbireoPharma’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of AlbireoPharma and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by…

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
AlbireoPharma Snapshot 5
AlbireoPharma Overview 5
Key Information 5
Key Facts 5
AlbireoPharma - Research and Development Overview 6
Key Therapeutic Areas 6
AlbireoPharma - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
AlbireoPharma - Pipeline Products Glance 11
AlbireoPharma - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
AlbireoPharma - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
AlbireoPharma - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
AlbireoPharma - Drug Profiles 15
elobixibat 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
A-3384 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
A-4250 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
A-3914 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
A-5425 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Drug to Inhibit IBAT for Type 2 Diabetes 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Drugs Agonizing PPAR for IBD 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AlbireoPharma - Pipeline Analysis 23
AlbireoPharma - Pipeline Products by Target 23
AlbireoPharma - Pipeline Products by Route of Administration 24
AlbireoPharma - Pipeline Products by Molecule Type 25
AlbireoPharma - Pipeline Products by Mechanism of Action 26
AlbireoPharma - Recent Pipeline Updates 27
AlbireoPharma - Dormant Projects 29
AlbireoPharma - Locations And Subsidiaries 30
Head Office 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 31
Disclaimer 32

For more information open AlbireoPharma - Product Pipeline Review - 2015.


Original Article: AlbireoPharma - Product Pipeline Review - 2015


More From BioPortfolio on "AlbireoPharma - Product Pipeline Review - 2015"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...